Prime Minister Shri Narendra Modi called upon the Indian pharmaceutical industry to intensify its focus on research and development (R&D) and aggressively pursue global patents, charting a decisive course for India’s evolving healthcare and life sciences sector.Speaking at the National Pharma Innovation Summit, PM Modi
The Indian pharmaceutical sector is strategically poised to capitalize on the recent healthcare initiatives introduced by President Donald Trump, aimed at enhancing the affordability and accessibility of medical treatments in the United States. This development presents significant opportunities for Indian drug manufacturers to expand their
